Case report: exome sequencing achieved a definite diagnosis in a Chinese family with muscle atrophy

[1]  Tan-Trung Nguyen,et al.  Novel GDAP1 Mutation in a Vietnamese Family with Charcot-Marie-Tooth Disease , 2019, BioMed research international.

[2]  M. Hirsch,et al.  Can a decision support system accelerate rare disease diagnosis? Evaluating the potential impact of Ada DX in a retrospective study , 2019, Orphanet Journal of Rare Diseases.

[3]  L. Richard,et al.  Rodent models with expression of PMP22: Relevance to dysmyelinating CMT and HNPP , 2019, Journal of the Neurological Sciences.

[4]  E. Chouery,et al.  The added value of WES reanalysis in the field of genetic diagnosis: lessons learned from 200 exomes in the Lebanese population , 2019, BMC Medical Genomics.

[5]  J. Satrústegui,et al.  Calcium Deregulation and Mitochondrial Bioenergetics in GDAP1-Related CMT Disease , 2019, International journal of molecular sciences.

[6]  N. Zelnik,et al.  Whole‐exome sequencing reveals a novel missense mutation in the MARS gene related to a rare Charcot‐Marie‐Tooth neuropathy type 2U , 2018, Journal of the peripheral nervous system : JPNS.

[7]  Yi-Chung Lee,et al.  Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2. , 2018, American journal of human genetics.

[8]  David R. FitzPatrick,et al.  Paediatric genomics: diagnosing rare disease in children , 2018, Nature Reviews Genetics.

[9]  David R. FitzPatrick,et al.  Paediatric genomics: diagnosing rare disease in children , 2018, Nature Reviews Genetics.

[10]  A. Al-Chalabi,et al.  Amyotrophic lateral sclerosis , 2017, The Lancet.

[11]  Yi Jiang,et al.  VarCards: an integrated genetic and clinical database for coding variants in the human genome , 2017, Nucleic Acids Res..

[12]  M. Sobrido,et al.  Phenotypical features of a new dominant GDAP1 pathogenic variant (p.R226del) in axonal Charcot-Marie-Tooth disease , 2017, Neuromuscular Disorders.

[13]  Jiang Li,et al.  Robust and rapid algorithms facilitate large-scale whole genome sequencing downstream analysis in an integrative framework , 2017, Nucleic acids research.

[14]  U. Suter,et al.  Glutathione-conjugating and membrane-remodeling activity of GDAP1 relies on amphipathic C-terminal domain , 2016, Scientific Reports.

[15]  S. Powers,et al.  Disease-Induced Skeletal Muscle Atrophy and Fatigue. , 2016, Medicine and science in sports and exercise.

[16]  P. Tsai,et al.  Clinical and biophysical characterization of 19 GJB1 mutations , 2016, Annals of clinical and translational neurology.

[17]  M. Schuelke,et al.  Nemaline body myopathy caused by a novel mutation in troponin T1 (TNNT1) , 2016, Muscle & nerve.

[18]  W. Chung,et al.  Clinical application of whole-exome sequencing across clinical indications , 2015, Genetics in Medicine.

[19]  W. Arnold,et al.  The genetics of Charcot – Marie – Tooth disease : current trends and future implications for diagnosis and management , 2015 .

[20]  Karynne E. Patterson,et al.  The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities. , 2015, American journal of human genetics.

[21]  S. Shimohama,et al.  A novel lamin A/C gene mutation causing spinal muscular atrophy phenotype with cardiac involvement: report of one case , 2015, BMC Neurology.

[22]  Bruno A. Cisterna,et al.  Neuronal involvement in muscular atrophy , 2014, Front. Cell. Neurosci..

[23]  A. Verma.  Next-generation sequencing and genetic diagnosis of Charcot-Marie-Tooth disease , 2014, Annals of Indian Academy of Neurology.

[24]  M. Russell,et al.  Genetic Diagnosis of Charcot-Marie-Tooth Disease in a Population by Next-Generation Sequencing , 2014, BioMed research international.

[25]  V. Nigro,et al.  Genetic basis of limb-girdle muscular dystrophies: the 2014 update , 2014, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[26]  Mustafa Tekin,et al.  The promise of whole-exome sequencing in medical genetics , 2013, Journal of Human Genetics.

[27]  D. Fink,et al.  HspB1 silences translation of PDZ-RhoGEF by enhancing miR-20a and miR-128 expression to promote neurite extension , 2013, Molecular and Cellular Neuroscience.

[28]  Byung-Ok Choi,et al.  Exome sequencing is an efficient tool for genetic screening of Charcot–Marie–Tooth Disease , 2012, Human mutation.

[29]  Johnny S. H. Kwan,et al.  A comprehensive framework for prioritizing variants in exome sequencing studies of Mendelian diseases , 2012, Nucleic acids research.

[30]  D. Cooper,et al.  Exome sequencing: Dual role as a discovery and diagnostic tool , 2012, Annals of neurology.

[31]  K. Fischbeck,et al.  Dominant GDAP1 mutations cause predominantly mild CMT phenotypes , 2011, Neurology.

[32]  M. Reilly,et al.  Charcot‐Marie‐Tooth disease , 2011, Journal of the peripheral nervous system : JPNS.

[33]  D. Bonneau,et al.  Mitochondrial dysfunction and pathophysiology of Charcot–Marie–Tooth disease involving GDAP1 mutations , 2011, Experimental Neurology.

[34]  Josyf Mychaleckyj,et al.  Robust relationship inference in genome-wide association studies , 2010, Bioinform..

[35]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[36]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[37]  M. Tan,et al.  Novel GDAP1 Mutation in a Turkish Family with CMT2K (CMT2K with Novel GDAP1 Mutation) , 2009, NeuroMolecular Medicine.

[38]  D. Bonneau,et al.  Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K) , 2009, neurogenetics.

[39]  Axel Niemann,et al.  Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network , 2005, The Journal of cell biology.

[40]  Manuel C. Peitsch,et al.  SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..

[41]  S. Züchner,et al.  Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy. , 2003, Brain : a journal of neurology.

[42]  V SCOLPINI,et al.  [Charcot-Marie-Tooth disease]. , 1950, Archivos de pediatria del Uruguay.

[43]  A. Kochański,et al.  A role for the GDAP1 gene in the molecular pathogenesis of Charcot‑Marie‑Tooth disease. , 2018, Acta neurobiologiae experimentalis.

[44]  A. Kochański,et al.  Charcot-Marie-Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potential. , 2012, Human molecular genetics.

[45]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.

[46]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..